Literature DB >> 6431426

Induced immunotolerance in factor VIII inhibitor patients.

H H Brackmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6431426

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  7 in total

Review 1.  State of care for hemophilia in pediatric patients.

Authors:  Elena Santagostino; Alessandro Gringeri; Pier M Mannucci
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Antibodies to factor VIII in plasma of patients with hemophilia A and normal subjects.

Authors:  J Batlle; E Gómez; E Rendal; J Torea; E Lourés; M Couselo; P Vila; C Sedano; X Tusell; M Magallón; M Quintana; R González-Boullosa; M F López-Fernández
Journal:  Ann Hematol       Date:  1996-05       Impact factor: 3.673

3.  Covalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.

Authors:  Stephanie Planque; Miguel A Escobar; Keri C Smith; Hiroaki Taguchi; Yasuhiro Nishiyama; Elizabeth Donnachie; Kathleen P Pratt; Sudhir Paul
Journal:  J Biol Chem       Date:  2008-03-11       Impact factor: 5.157

4.  Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies.

Authors:  I M Nilsson; E Berntorp; O Zettervall
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 5.  Treatment strategies in children with hemophilia.

Authors:  Pia Petrini
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 6.  Desensitization and immune tolerance induction in children with severe factor IX deficiency; inhibitors and adverse reactions to replacement therapy: a case-report and literature review.

Authors:  Andrea Bon; Massimo Morfini; Alessandro Dini; Francesca Mori; Simona Barni; Sottilotta Gianluca; Maurizio de Martino; Elio Novembre
Journal:  Ital J Pediatr       Date:  2015-02-19       Impact factor: 2.638

7.  Origins, Development, Current Challenges and Future Directions with Activated Prothrombin Complex Concentrate for the Treatment of Patients with Congenital Haemophilia with Inhibitors.

Authors:  Hans H Brackmann; Wolfgang Schramm; Johannes Oldenburg; Viridiana Cano; Peter L Turecek; Claude Négrier
Journal:  Hamostaseologie       Date:  2020-07-27       Impact factor: 2.145
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.